Why Regencell Bioscience Holdings Limited’s (RGC) Stock Is Down 8.06%
As of Tuesday, October 20, Regencell Bioscience Holdings Limited’s RGC share price has dipped by 8.06%, which has investors questioning if this is right time to buy.Michael Rose
Stock Evaluator: Regencell Bioscience Holdings Limited (RGC)
Regencell Bioscience Holdings Limited RGC
$10.45
0.40
3.98%
October 20, 2026 4:00:00 PM
EST
Volume: 391,484
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Pharmaceuticals |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Commentary & Analysis
Why Regencell Bioscience Holdings Limited’s (RGC) Stock Is Up 11.16%
As of Monday, October 19, Regencell Bioscience Holdings Limited’s RGC share price has surged by 11.16%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Regencell Bioscience Holdings Limited’s (RGC) Stock Is Down 5.88%
As of Friday, October 16, Regencell Bioscience Holdings Limited’s RGC share price has dipped by 5.88%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Regencell Bioscience Holdings Limited’s (RGC) Stock Is Up 15.66%
As of Thursday, October 15, Regencell Bioscience Holdings Limited’s RGC share price has surged by 15.66%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Regencell Bioscience Holdings Limited’s (RGC) Stock Is Up 16.28%
As of Thursday, October 15, Regencell Bioscience Holdings Limited’s RGC share price has surged by 16.28%, which has investors questioning if this is right time to sell.Omar Beirat
Financial Summary
| Share Statistics | RGC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5,117.5 | $474.3 | 68% |
|
| Shares Out (Mil) | 494.7 | 42.7 | 88% |
|
| Institutional Ownership | 0.4% | 81.2% | 1% |
|
| Float (Mil) | 55.6 | 44.3 | 49% |
|
| Beta | 1.17 | 0.73 | 69% |
|
| Avg Daily Volume (000s) | 566 | 339 | 60% |
|
| Price Change (52-week) |
(40.7%) | 56.0% | 24% |
|
| Growth | RGC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.1% | na |
|
| Net Income (5yr) | (55.2%) | (2.4%) | 6% |
|
| EPS (5yr) | (43.1%) | 14.9% | 5 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.1%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | RGC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $416 | na |
|
| Net Income (TTM) (Mil) | ($12) | ($11) | 28% |
|
| EPS (TTM) | ($0.024) | ($0.700) | 38% |
|
| Operating Cash Flow (TTM) (Mil) | ($8) | ($7) | 22% |
|
| Net Cash Flow (TTM) (Mil) | na | $6 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $6 | 10% |
|
| Enterprise Value (Q1) (Mil) | $4,707 | $493 | 62% |
|
| Valuation | RGC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 344.00 | 2.16 | 100% |
|
| P/E | na | 17.4 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | RGC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 69.4% | na |
|
| Net Margin | na | 3.2% | na |
|
| ROA | (114.2%) | (22.2%) | 5% |
|
| ROE | (128.5%) | (21.0%) | 7% |
|
| Liabilities to Assets | 9.4% | 32.3% | 6% |
|
| F-Score | 3 | 3 | 18% |
|
Regencell Bioscience Holdings Limited did not pass any screens on 10/20/2026.
